Our findings suggest that eccDNAs induced by intrinsic DNA damage can activate STING signalling in cancer cells, which offers insights into why some DLBCL patients are prone to disease recurrence with the R‐CHOP strategy. This evidence concerns the gene STING1 and diffuse large B-cell lymphoma.